ADVANCING MOST-FAVORED-NATION PRICING: Today, President Donald J. Trump announced the second agreement with a major pharmaceutical company, AstraZeneca, to bring American drug prices in line with the lowest paid by other developed nations (known as the most-favored-nation, or MFN, price). The agreement will provide every State Medicaid program in the country access to MFN drug prices on AstraZeneca products, resulting in hundreds of millions of dollars in savings and continuing President Trump’s historic efforts to strengthen the program for the most vulnerable...